1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > United States Microbiology Culture Market Outlook to 2021

United States Microbiology Culture Market Outlook to 2021

Summary

GlobalData’s new report, "United States Microbiology Culture Market Outlook to 2021", provides key market data on the United States Microbiology Culture market. The report provides value, in millions of US dollars within market segments - Microbiology Analyzers, Mycobacteria Culture, Blood Culture, Bacterial Identification & Susceptibility Testing, Immunological Culture Identification, Parasitology Culture and Mycology Culture.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Microbiology Culture market includes Microbiology Analyzers, Mycobacteria Culture, Blood Culture, Bacterial Identification & Susceptibility Testing, Immunological Culture Identification, Parasitology Culture and Mycology Culture.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Microbiology Culture market.
- Global corporate-level profiles of key companies operating within the United States Microbiology Culture market.
- Key players covered include Becton, Dickinson and Company, bioMerieux S.A., Siemens Healthcare, Danaher Corporation, Alere Inc. and Thermo Fisher Scientific Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Microbiology Culture Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Microbiology Culture Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Microbiology Culture Market, United States 7
3.1 Microbiology Culture Market, United States, Revenue ($m), 2007-2014 7
3.2 Microbiology Culture Market, United States, Revenue ($m), 2014-2021 9
3.2.1 Microbiology Analyzers Market, United States, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Microbiology Analyzers Market, United States, Revenue ($m), by Segment, 2014-2021 13
3.3 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2013-2014 15
3.4 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2014 16
4 Overview of Key Companies in United States, Microbiology Culture Market 18
4.1 Becton, Dickinson and Company 18
4.1.1 Company Overview 18
4.2 Siemens Healthcare 18
4.2.1 Company Overview 18
4.3 bioMerieux S.A. 18
4.3.1 Company Overview 18
4.4 Danaher Corporation 19
4.4.1 Company Overview 19
4.5 Alere Inc. 19
4.5.1 Company Overview 19
4.6 Thermo Fisher Scientific Inc. 19
4.6.1 Company Overview 19
4.7 Bio-Rad Laboratories, Inc. 20
4.7.1 Company Overview 20
5 Financial Deals Landscape 21
5.1 Acquisition 21
5.1.1 Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 21
5.2 Debt Offerings 24
5.2.1 LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 24
5.2.2 LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 26
5.2.3 LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 28
5.2.4 LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 30
5.2.5 Quidel Prices Public Offering of 3.25% Senior Notes Due 2020 32
5.3 Equity Offerings 34
5.3.1 Organovo Prices Public Offering of Shares for USD40 Million 34
5.3.2 Vivione Biosciences to Raise USD8 Million in Private Placement of Shares 36
5.4 Partnerships 37
5.4.1 Genewiz Forms Joint Venture with Hy Labs 37
5.4.2 NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 38
5.5 Venture Financing 39
5.5.1 Lucigen Raises USD2.2 Million in Venture Financing 39
5.5.2 Metabolon Raises USD5 Million in Venture Financing 40
5.5.3 Verax Biomedical Raises USD4 Million in Venture Financing 41
6 Appendix 42
6.1 Research Methodology 43
6.1.1 Coverage 43
6.1.2 Secondary Research 43
6.1.3 Primary Research 44
6.1.4 Company Share Analysis 44
6.1.5 Distribution Share Analysis 44
6.2 GlobalData Consulting 44
6.3 Contact Us 45
6.4 Disclaimer 45

1.1 List of Tables
Table 1: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Microbiology Culture Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 15
Table 6: Microbiology Culture Market, United States, Company Share by Revenue ($m), USD Constant, 2014 17
Table 7: Opko Health to Acquire Bio-Reference Labs for USD1.47 Billion 21
Table 8: LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 24
Table 9: LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 26
Table 10: LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 28
Table 11: LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 30
Table 12: Quidel Prices Public Offering of 3.25% Senior Notes Due 2020 32
Table 13: Organovo Prices Public Offering of Shares for USD40 Million 34
Table 14: Vivione Biosciences to Raise USD8 Million in Private Placement of Shares 36
Table 15: Genewiz Forms Joint Venture with Hy Labs 37
Table 16: NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 38
Table 17: Lucigen Raises USD2.2 Million in Venture Financing 39
Table 18: Metabolon Raises USD5 Million in Venture Financing 40
Table 19: Verax Biomedical Raises USD4 Million in Venture Financing 41

1.2 List of Figures
Figure 1: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Microbiology Culture Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Microbiology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Microbiology Culture Market, United States, Company Share (%) 2014 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.